BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10069729)

  • 1. False-positive result of a total-body scan caused by benign thyroidal tissue after I-131 ablation.
    Coover LR
    Clin Nucl Med; 1999 Mar; 24(3):182-3. PubMed ID: 10069729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postsurgical thyroid remnant estimation by (⁹⁹m) Tc-pertechnetate scintigraphy predicts radioiodine ablation effectiveness in patients with differentiated thyroid carcinoma.
    Giovanella L; Suriano S; Ricci R; Ceriani L; Anton Verburg F
    Head Neck; 2011 Apr; 33(4):552-6. PubMed ID: 20824809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid remnant ablation in patients with papillary cancer: a comparison of low, moderate, and high activities of radioiodine.
    Kusacic Kuna S; Samardzic T; Tesic V; Medvedec M; Kuna K; Bracic I; Despot M; Dodig D
    Nucl Med Commun; 2009 Apr; 30(4):263-9. PubMed ID: 19247212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technetium-99m-pertechnetate whole-body SPET/CT scan in thyroidectomized differentiated thyroid cancer patients is a useful imaging modality in detecting remnant thyroid tissue, nodal and distant metastases before
    Lou K; Gu Y; Hu Y; Wang S; Shi H
    Hell J Nucl Med; 2018; 21(2):121-124. PubMed ID: 30089313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation of post-operative radioiodine uptake and Tc-99m pertechnetate thyroid scintigraphy and the result of thyroid remnant ablation.
    Thientunyakit T; Pusuwan P; Tuchinda P; Khiewvan B
    J Med Assoc Thai; 2013 Sep; 96(9):1199-207. PubMed ID: 24163997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial stunning in thyroid remnant after administration of scanning dose followed by 100 mCi I-131 therapy.
    Yagcloglu H; Ozalp E; Ibis E; Aras G
    Clin Nucl Med; 1996 Apr; 21(4):340. PubMed ID: 8925630
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pericardial effusion as a possible cause of false positives in I-131 radionuclide scans].
    López Aznar D; García Sanchís L; Rivas Sánchez A; Alonso Monfort J; Hervás Benito I; Mateo Navarro A
    Rev Esp Med Nucl; 1998; 17(3):158-61. PubMed ID: 9683854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of low doses of I-131 for thyroid ablation in postsurgical patients with thyroid carcinoma.
    Siddiqui AR; Edmondson J; Wellman HN; Hamaker RC; Lingeman RE; Park HM; Johnston CC
    Clin Nucl Med; 1981 Apr; 6(4):158-61. PubMed ID: 7214770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of radioiodine therapy and radiofrequency ablation in treating postsurgical thyroid remnant of differentiated thyroid carcinoma.
    Long B; Li L; Yao L; Chen S; Yi H; Ye X; Xu D; Wu P
    J Cancer Res Ther; 2015 Nov; 11 Suppl():C244-7. PubMed ID: 26612446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced scintigraphic visualization of thyroglossal duct remnant during hypothyroidism after total thyroidectomy: prevalence and clinical implication in patients with differentiated thyroid cancer.
    Lee SW; Lee J; Lee HJ; Seo JH; Kang SM; Bae JH; Ahn BC
    Thyroid; 2007 Apr; 17(4):341-6. PubMed ID: 17465864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
    Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
    J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes after (123)I versus (131)I pre-ablation imaging before radioiodine ablation in differentiated thyroid carcinoma.
    Silberstein EB
    J Nucl Med; 2007 Jul; 48(7):1043-6. PubMed ID: 17574976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of benign from malignant nodules by accumulation of Tc-99m pertechnetate using TI-201 delayed scans.
    Okumura Y; Takeda Y; Sato S; Shimizu M; Komatsu M; Honda O; Nakagawa T; Niiya H; Hiraki Y
    Clin Nucl Med; 1998 Aug; 23(8):514-6. PubMed ID: 9712383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the factors affecting the efficacy of (131)I remnant ablation in patients after thyroidectomy for papillary thyroid microcarcinoma].
    Du F; Hu S; Wu C; Cheng Y; Wu LX; Liu JZ; Wu ZF; Li SJ
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):610-613. PubMed ID: 30139032
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of the efficacy of iodine-131 for thyroid ablation.
    Comtois R; Thériault C; Del Vecchio P
    J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Papillary thyroid carcinoma in a median ectopic thyroid associated with intra-abdominal thyroid tissue].
    Hoffmann R; Bubeck B; Raue F
    Dtsch Med Wochenschr; 1991 Apr; 116(17):654-8. PubMed ID: 1902162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scintigraphic visualization of glossal thyroid tissue during the follow-up of thyroid cancer patients.
    Zanotti-Fregonara P; Hindié E; Keller I; Calzada-Nocaudie M; Devaux JY
    Clin Nucl Med; 2007 Dec; 32(12):911-4. PubMed ID: 18030039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental Gallbladder Cancer Visualized From Posttreatment 131I Whole-Body Scan.
    Anongpornjossakul Y; Utamakul C; Chamroonrat W; Kositwattanarerk A; Thamnirat K; Sritara C
    Clin Nucl Med; 2016 Mar; 41(3):e162-3. PubMed ID: 26447377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.
    Schmidt M; Dietlein M; Schröder U; Schicha H
    Clin Nucl Med; 2006 Nov; 31(11):716-7. PubMed ID: 17053394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.